Показано 0 из 0
Дата |
---|
06:53 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
40.63
|
40.70
|
39.72
|
39.62
|
40.91
|
40.63
|
|
|
162 917 328.00
|
|
|
|
40.06
|
39.00
|
40.19
|
39.07
|
|
|
150 537 167.00
|
|
|
|
38.73
|
38.51
|
40.30
|
39.99
|
|
|
246 558 575.00
|
|
|
|
38.21
|
38.21
|
38.95
|
38.55
|
|
|
203 326 203.00
|
|
|
|
39.32
|
38.53
|
39.57
|
38.53
|
|
|
144 362 722.00
|
|
|
|
40.10
|
39.10
|
40.31
|
39.28
|
|
|
115 495 280.00
|
|
|
|
39.66
|
38.38
|
40.48
|
40.26
|
|
|
175 753 264.00
|
|
|
|
40.40
|
39.03
|
40.75
|
39.75
|
|
|
157 871 590.00
|
|
|
|
41.01
|
40.00
|
41.34
|
40.50
|
|
|
105 117 591.00
|
|
|
|
40.86
|
40.29
|
42.17
|
41.31
|
|
|
122 531 608.00
|
|
Changchun BCHT Biotechnology Co is a China-based innovative biomedical company mainly dedicated to the prevention and treatment of infectious diseases. The Company is mainly engaged in the research and development, production and sales of human vaccines. The Company has three approved vaccine products: varicella vaccine, rabies vaccine and freeze-dried nasal spray flu vaccine. The Company also has other vaccines under development and fully human monoclonal antibody under development for the prevention and control of infectious diseases. The Company mainly conducts business within the domestic market.